Unknown

Dataset Information

0

Prognostic significance of interleukin 17 in cancer: a meta-analysis.


ABSTRACT: The prognostic value of Interleukin 17 (IL-17) in cancer patients is currently under debate and remains inconclusive. We performed a systematic review and meta-analysis to evaluate the role of IL-17 as a prognostic marker in cancer. Hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) were combined to measure the effective value of IL-17 expression on prognosis. Nineteen eligible studies enrolling 2390 patients were identified. We found expression of IL-17 was not significantly correlated with overall survival (OS) in cancer (HR=1.29, 95% Cl: 0.94-1.76; P=0.12). Furthermore, compared to the data from our analysis that high expression of IL-17 predicted poor OS in both non-small cell lung carcinoma (NSCLC) (HR=2.30; 95% CI: 1.45-3.64; P<0.001; I(2)=0%) and hepatocellular carcinoma (HCC) (HR=2.02; 95% CI: 1.44-2.83; P<0.001; I(2)=0%), high expression of IL-17 was associated with favorable OS in esophageal squamous cell carcinoma (ESCC) (HR=0.63; 95% CI: 0.51-0.79; P<0.001; I(2)=0%). This meta-analysis showed that IL-17 has the potential to become a novel prognostic marker in HCC, NSCLC and ESCC. It could potentially help to monitor patients' prognosis and assess therapeutic efficacy in clinical treatment.

SUBMITTER: Zhang X 

PROVIDER: S-EPMC4238499 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prognostic significance of interleukin 17 in cancer: a meta-analysis.

Zhang Xiao X   Weng Wenhao W   Xu Wen W   Wang Yulan Y   Yu Wenjun W   Tang Xun X   Ma Lifang L   Pan Qiuhui Q   Wang Jiayi J   Sun Fenyong F  

International journal of clinical and experimental medicine 20141015 10


The prognostic value of Interleukin 17 (IL-17) in cancer patients is currently under debate and remains inconclusive. We performed a systematic review and meta-analysis to evaluate the role of IL-17 as a prognostic marker in cancer. Hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) were combined to measure the effective value of IL-17 expression on prognosis. Nineteen eligible studies enrolling 2390 patients were identified. We found expression of IL-17 was not significantly c  ...[more]

Similar Datasets

| S-EPMC6054760 | biostudies-literature
| S-EPMC6609818 | biostudies-literature
| S-EPMC5608354 | biostudies-literature
| S-EPMC5617510 | biostudies-other
| S-EPMC7404708 | biostudies-literature
| S-EPMC5973851 | biostudies-other
| S-EPMC5988310 | biostudies-other
| S-EPMC4831352 | biostudies-other
| S-EPMC4307447 | biostudies-literature
| S-EPMC4709684 | biostudies-other